Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Academic Enterprise Awards 2013

Publication date: Jan 30, 2013 09:29 AM

Start: Jun 04, 2013 09:00 AM

ACES 2013

The ACES - Academic Enterprise Awards - are the only pan-European awards for spin-out companies emerged from European universities and public research centres. The ACES programme is presented by the Science|Business Innovation Board.

Nominations for the ACES 2013 are now open. This year, nominated spin-outs compete for the four following awards:

  • Life Sciences Award - For spin-outs based on research in pharmaceuticals, biotechnology, medical devices, diagnostics and other life sciences sectors.
  • Materials & Chemicals Award - For spin-outs based on research in new materials, chemicals or engineering sectors.
  • Energy & Environment Award - For spin-outs based on research in energy, climate and environment technologies.
  • ICT Award - For spin-outs based on research in computer, telecommunications, online hardware, software, services and sectoral application of ICT (e.g. e-health)

The 5th edition of the Academic Enterprise Awards will be celebrated in a conference hosted by Vice-President of the European Parliament Alexander Alvaro on 4 June 2013.

Find out more at www.sciencebusiness.net/aces